INDIAN BENCHMARKS are likely to start
the session on a subued note as the global cues look muted with SGX Nifty
trading 108.50 points lower.
- Lupin receive USFDA approval for Fenofibrate tablets
- Maruti increases prices of vehicles by Rs3,000-9,000
- Ageas likely to hike stake in IDBI Federal Life
Post a Comment